Meeting on the Mesa 2021 | Innovative regulatory pathways for next-generation treatments

Jeff Ross, PhD, Miromatrix, Eden Prairie, MN, provides a brief overview of the topics discussed at the “Innovative regulatory pathways for next-generation treatments” session at Meeting on the Mesa 2021. Novel products and technologies result in unique regulatory pathways and Dr Ross describes his experiences with regulatory authorities. He additionally highlights INTERACT meetings with the FDA, which enables companies to receive guidance on the development of their products. This interview took place at Meeting on the Mesa 2021.